Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010-2019.
17 Oct, 2022 | 12:12h | UTC
Commentary on Twitter
Underrepresentation of adults above age 75-80 years found in evaluation of new medications. 60-75 year-olds were reasonably well represented in clinical trials in proportion to the prevalence data in the US. #OAResearch https://t.co/2RL5fTo3LA
— JAMA Network Open (@JAMANetworkOpen) October 14, 2022